<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is characterized by arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="1" pm="."><plain>We measured Î²2-GPI aCL, IgGaCL, LA, antiphosphatidyl-serine antibody (PS), and antiphosphatidyl-<z:chebi fb="1" ids="24848">inositol</z:chebi> antibody (PI) in each patient at one month after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, carotid artery echography was performed in patients positive for PI or PS </plain></SENT>
<SENT sid="3" pm="."><plain>Among the 250 patients, 13.6% (34/250) were positive for either PI or PS, and 6.8% (17/250) were positive for both </plain></SENT>
<SENT sid="4" pm="."><plain>Carotid artery echography performed on these 34 patients showed that the frequencies of increased intimal-medial thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) of 1.1 mm or more, plaque, and carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp> of 50% or more were <z:hpo ids='HP_0000001'>all</z:hpo> significantly higher in patients positive for antinuclear antibody than those negative for the antibody (P &lt; .05) </plain></SENT>
<SENT sid="5" pm="."><plain>PI and PS are associated with antinuclear antibody and precipitation of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> patients with SLE frequently showed a variety of antiphospholipid-protein antibodies </plain></SENT>
</text></document>